<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00324584</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 03 01</org_study_id>
    <nct_id>NCT00324584</nct_id>
  </id_info>
  <brief_title>Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study</brief_title>
  <official_title>Surveillance Des données De l’Autosurveillance glycémique Via Internet Et Le réseau téléphonique GSM Chez Le diabétique De Type 1 Sous Traitement Insulinique Par Pompe Externe : Etude Prospective randomisée PumpNet.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if telecare using modern telecommunication devices
      can improve the metabolic control and the quality of life of type 1 diabetic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We aim at comparing conventional follow-up of type 1 diabetic patients treated with
      continuous subcutaneous insulin infusion (CSII) (face-to-face visits) with an intensive
      coaching using the Web and the cellular phone network for data transmission and Short Message
      Service (SMS). This telecommunication device is called GlucoNet. The specific objectives are
      to measure the efficiency of GlucoNet in improving metabolic control, reducing health care
      costs and improving the quality of life of patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date>September 2004</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated hemoglobin HbA1c</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>monthly mean capillary blood glucose value</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>blood glucose variability index (MAGE Index and LBGI index)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>quality of life score (DQOL score)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>frequency of hypoglycemic episodes (&lt;70 mg/dl)</measure>
  </primary_outcome>
  <enrollment>40</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemonitoring of glucose values using GlucoNet device</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes mellitus

          -  Age ≥ 18

          -  HbA1c between 7.5 and 10%

          -  Treated with continuous subcutaneous insulin infusion for a minimum of 3 months

        Exclusion Criteria:

          -  Unstabilized diabetic microangiopathy

          -  Ongoing pregnancy or planned pregnancy

          -  Unwilling to perform a minimum of 4 capillary blood tests per day

          -  Unable to use the GlucoNet device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Y Benhamou, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universty Hospital, Grenoble, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helene Hanaire, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Toulouse, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Serge Halimi, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Grenoble, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean L Bosson, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CIC-INSERM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Department of Endocrinology</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital, Department of Endocrinology</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2006</study_first_submitted>
  <study_first_submitted_qc>May 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2006</study_first_posted>
  <last_update_submitted>July 4, 2006</last_update_submitted>
  <last_update_submitted_qc>July 4, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2006</last_update_posted>
  <keyword>type 1 diabetes mellitus</keyword>
  <keyword>telecare</keyword>
  <keyword>telemedicine</keyword>
  <keyword>insulin pump therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

